Abstract:Objective: To analyze the application value of a whole blood gamma-interferon release test (TB-IGRA) and a tuberculosis antibody test (TB-Ab) in the differential diagnosis of pulmonary tuberculosis. Methods: A total of 167 patients admitted to our hospital from January 2019 to January 2020 were divided into the tuberculosis group (n=80) and the pneumonia group (n=87) according to the pathological examination of the patients. All patients underwent TB-IGRA and TB-Ab examinations within 24 hours of admission. Next, the negative-positive ratios of TB-IGRA, TB-Ab, and sputum specimens in each group were compared. The possible risk factors of TB-IGRA and TB-Ab test false positives were analyzed, and the diagnostic values of TB-IGRA and TB-Ab alone and in combination in the differential diagnoses of tuberculosis were analyzed using an ROC curve. Results: Compared with the pathological results, the positive rate of TB-IGRA for identifying tuberculosis was 91.25%, the negative rate was 8.75%. In addition, the positive rate for identifying pneumonia was 21.84%, and the negative rate was 78.16%. The positive rate of TB-IGRA for identifying tuberculosis was 86.25%, and the negative rate was 13.75%. The positive rate for identifying pneumonia was 28.74%, and the negative rate was 71.26%. The positive rate of sputum smears for identifying tuberculosis was 22.50%, and the negative rate was 77.50%. The positive rate for identifying pneumonia was 2.30%, and the negative rate was 97.70%. Among the 83 tuberculosis patients, 73 were true positives of TB-IGRA, and seven were false negatives. Analysis of the factors that may cause false negatives of TB-IGRA showed that age (>= 65 years) and lymphocyte decrease (<1.1x109), WBC (>9.5x109), absolute value of neutrophils (>6.3x109), CRP (>100mg/l), tumors, diabetes, pleural effusion, and fever were not factors leading to false negatives (P>0.05). The ROC curve analysis showed that the AUC of TB-IGRA in the differential diagnosis of tuberculosis was 0.847, the sensitivity was 92.65%, and the specificity was 85.16%. Furthermore, the AUC of TB-AB in the differential diagnosis of tuberculosis was 0.788, the sensitivity was 85.26%, and the specificity was 72.24%. The AUC of the two parallel tests to diagnose and differentiate tuberculosis was 0.757, the sensitivity was 95.00%, and the specificity was 54.02%. The AUC of the two systems to diagnose and differentiate tuberculosis was 0.878, the sensitivity was 82.50%, and the specificity was 93.10%. Conclusion: Compared with the pathological results, TB-IGRA and TB-Ab have higher positive rates in the diagnoses of pulmonary tuberculosis. Among them, age, lymphocyte reduction, infection status, tumor, diabetes, and their complications are not factors causing TB-IGRA false negatives, which is better than TB-Ab, which can be widely used in a clinical setting.

Diagnostic Value of TB-IGRA, PPD, TB-DNA-PCR and ADA in Tuberculous Pleural Effusion

The Diagnostic Efficiency Evaluation of Combination Tuberculosis Interferon-Gamma Release Assay with Human Leukocyte Antigen-G for Tuberculosis

Value of the Early Diagnosis of Polymerase Chain Reaction for Exudative Tuberculous Pleurisy

Diagnostic value of hydrothorax T-cell spot test combined with adenosine deaminase for tuberculous pleurisy

The value of single or combined use of pleural fluid interferon gamma release assay in the diagnosis of tuberculous pleurisy

Comparison of Laboratory Testing Methods for the Diagnosis of Tuberculous Pleurisy in China

Improved diagnostic power by combined interferon-gamma release assay and nested-PCR in tuberculous pleurisy in high tuberculosis prevalence area.

The Diagnostic Value of T-cell Enzyme-linked Immunosorbent Spot Assay in Tuberculous Pleurisy

Diagnostic Value of Medical Thoracoscopy, T-SPOT and ADA in Tuberculous Pleurisy

Use of T-SPOT.TB for the Diagnosis of Unconventional Pleural Tuberculosis is Superior to ADA in High Prevalence Areas: a Prospective Analysis of 601 Cases

Diagnostic Value of Polymerase Chain Reaction/acid-Fast Bacilli in Conjunction with Computed Tomography–guided Pleural Biopsy in Tuberculous Pleurisy

Diagnostic value of IFN-gamma in tuberculous pleural effusion

Assessment of the diagnostic power by interferon-gamma release of the whole blood and pleural biopsy in tuberculous pleurisy

The application value of tb-igra and tb-ab in the differential diagnosis of pulmonary tuberculosis

Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion

Clinical Diagnostic Utility of Adenosine Deaminase, Interferon-Γ, Interferon-Γ–induced Protein of 10 Kda, and Dipeptidyl Peptidase 4 Levels in Tuberculous Pleural Effusions

Clinical Investigation on Diagnostic Value of Interferon-Gamma, Interleukin-12 and Adenosine Deaminase Isoenzyme for Tuberculous Pleurisy.

Clinical evaluation of diagnosing pleural tuberculosis

A Combination Of The Quantiferon-Tb Gold In-Tube Assay And The Detection Of Adenosine Deaminase Improves The Diagnosis Of Tuberculous Pleural Effusion

Clinical investigation on diagnostic value of interferon-γ, interleukin-12 and adenosine deaminase isoenzyme for tuberculous pleurisy

Evaluation of droplet digital polymerase chain reaction by detecting cell-free deoxyribonucleic acid in pleural effusion for the diagnosis of tuberculous pleurisy: a multicentre cohort study